xcellbio

📍 San Francisco, United States👥 30 employees💰 Last funded Nov 2021
Biotechnology Research🌐 xcellbio.com
Website LinkedIn
Xcell Biosciences (xcellbio) is a San Francisco-based life science company dedicated to bringing an innovative primary cell control solution to the immunotherapy market to support research, drug discovery, and cell manufacturing. Xcell’s mission is to democratize maintenance, expansion and control of any primary cell type through its bench-top primary cell control systems, reagent kits, software, and standardized protocols. The technology delivers simple control of primary cell types from blood or solid tissue, including a range of immune cells, stem cells, and tumor cells. This patient-centric technology offers a unique and proprietary capability to improve immunotherapy efficacy, safety, and persistence through more predictive and iterative therapy development and rapid, highly-controlled clinical cell manufacturing. For more information, please visit http://www.xcellbio.com/.
4
Total investors
0
Early stage
2
Mid stage
1
Late stage
—
Founded

Investors

4 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
3
Brazil
1
Investor activity2015–2021 · investors recorded per year
201522018120211
Recent (last 2y)Earlier
Frequently asked questions
Who invested in xcellbio?
xcellbio has 4 investors on record on gritt.io, 2 mid-stage and 1 late-stage investors.
When did xcellbio last raise funding?
The most recent investment in xcellbio recorded on gritt.io was in November 2021.
What industry is xcellbio in?
xcellbio operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is xcellbio based?
xcellbio is headquartered in San Francisco, United States.